Skip to Content
COVID-19 Resources
Cancer Therapy Evaluation Program (CTEP)
Contact NExT
Show menu
Search this site
Last Updated: 03/26/20

Steven Gore, MD, Physician

Steven Gore, MD, Physician

Steven Gore, MD, earned his undergraduate and doctoral degrees at Yale, performed his residency at the University of Chicago and his oncology fellowship at Johns Hopkins. He rose from instructor to full professor at Johns Hopkins, and, in 2013, he became professor of medicine and director of hematologic malignancies at Yale.

Dr. Gore is an internationally recognized expert in drug development in leukemia. His research career focused on the development of drugs with epigenetic targets for the treatment of myeloid disease, and he has played a major role in the incorporation of epigenetic modifiers in the treatment of myeloid malignancies. Among his many other accomplishments, Dr. Gore has been on the NCI Leukemia Steering Committee since 2015 and became co-chair in 2017. Dr. Gore is author or co-author of over 200 scholarly publications including primary research papers, book chapters, books, reviews, and practice guidelines. 

About the Branch Chief

Jeffrey A. Moscow, MD Jeffrey A. Moscow, MD, joined the Investigational Drug Branch (IDB) in 2014 after serving part time since 2012, and was appointed Branch Chief in 2018. He is a graduate of Harvard University and the Geisel School of Medicine at Dartmouth. Dr. Moscow completed his pediatric residency at the University of Texas Southwestern in Dallas and a fellowship in pediatric hematology-oncology in the Pediatric Oncology Branch, NCI. More…